Hunt Anthony — SEC insider filings

SEC reporting owner CIK 1606030. 53 insider filings on record with FilingPulse; latest filed 2026-10-08.

Transaction summary — filings shown

Covers the 50 most recent of 53 filings on record, filed 2021-03-08 to 2026-10-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
REPLIGEN CORP (RGEN)Director381 leg · 2,000 sh · $248,16093 legs · 382,358 sh · $68,945,03762
908 Devices Inc. (MASS)Director9——26
BIOLIFE SOLUTIONS INC (BLFS)Director3——3

Insider filings — Hunt Anthony

FiledFormIssuerReported transactionsSource
2026-10-084BIOLIFE SOLUTIONS INC (BLFS)Disposition to issuer (D): 15,046EDGAR
2026-06-124908 Devices Inc. (MASS)Option exercise (M): 14,083 · Option exercise (M): 14,083 (derivative) @ $0 · Grant/award (A): 13,656 (derivative) @ $0 · Grant/award (A): 6,209 (derivative) @ $0EDGAR
2026-03-034REPLIGEN CORP (RGEN)Tax withholding (F): 9,897 @ $124.97EDGAR
2026-02-264BIOLIFE SOLUTIONS INC (BLFS)Grant/award (A): 8,170EDGAR
2025-12-084REPLIGEN CORP (RGEN)Other (J): 2,000EDGAR
2025-11-144REPLIGEN CORP (RGEN)Sale (S): 1,784 @ $151.01 · Sale (S): 2,100 @ $152.17 · Sale (S): 2,923 @ $153.14 · Sale (S): 2,500 @ $154.32 · Sale (S): 3,000 @ $155.45 · Sale (S): 5,737 @ $156.22 · +3 moreEDGAR
2025-11-134REPLIGEN CORP (RGEN)Option exercise (M): 25,000 @ $33.87 · Sale (S): 3,741 @ $154.92 · Sale (S): 4,740 @ $155.85 · Sale (S): 4,959 @ $156.65 · Sale (S): 11,096 @ $158.01 · Sale (S): 464 @ $158.51 · +1 moreEDGAR
2025-09-114REPLIGEN CORP (RGEN)Option exercise (M): 20,000 @ $33.87 · Sale (S): 96 @ $116.34 · Sale (S): 1,108 @ $118.32 · Sale (S): 3,262 @ $119.64 · Sale (S): 14,882 @ $120.19 · Sale (S): 7,584 @ $121.42 · +2 moreEDGAR
2025-06-134908 Devices Inc. (MASS)Option exercise (M): 11,364 · Option exercise (M): 11,364 (derivative) @ $0 · Grant/award (A): 14,083 (derivative) @ $0 · Grant/award (A): 6,516 (derivative) @ $0EDGAR
2025-05-164REPLIGEN CORP (RGEN)Sale (S): 2,043 @ $122.66 · Sale (S): 17,596 @ $123.57 · Sale (S): 6,533 @ $124.34 · Sale (S): 268 @ $125.20 · Sale (S): 7 @ $127EDGAR
2025-03-204BIOLIFE SOLUTIONS INC (BLFS)Grant/award (A): 6,876EDGAR
2025-03-194REPLIGEN CORP (RGEN)Option exercise (M): 5,000 @ $33.87 · Option exercise (M): 21,756 @ $59.52 · Sale (S): 60 @ $148.05 · Sale (S): 100 @ $150.38 · Sale (S): 2,518 @ $151.09 · Sale (S): 6,176 @ $151.96 · +4 moreEDGAR
2025-03-044908 Devices Inc. (MASS)Option exercise (M): 2,058 · Option exercise (M): 2,058 (derivative) @ $0EDGAR
2025-03-044REPLIGEN CORP (RGEN)Tax withholding (F): 10,142 @ $155.38EDGAR
2025-02-284REPLIGEN CORP (RGEN)Tax withholding (F): 2,825 @ $156.54EDGAR
2025-02-254REPLIGEN CORP (RGEN)Tax withholding (F): 2,380 @ $164.74EDGAR
2024-12-054REPLIGEN CORP (RGEN)Option exercise (M): 11,808 @ $33.87 · Option exercise (M): 11,808 (derivative) @ $0EDGAR
2024-11-224REPLIGEN CORP (RGEN)Option exercise (M): 24,246 @ $33.87 · Sale (S): 24,246 @ $139.67 · Option exercise (M): 24,246 (derivative) @ $0EDGAR
2024-09-124REPLIGEN CORP (RGEN)Option exercise (M): 10,000 @ $33.87 · Sale (S): 1,495 @ $143.77 · Sale (S): 9,369 @ $144.88 · Sale (S): 10,723 @ $145.95 · Sale (S): 604 @ $146.67 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2024-09-044REPLIGEN CORP (RGEN)Disposition to issuer (D): 13,146 @ $0 · Disposition to issuer (D): 13,057 (derivative) @ $0EDGAR
2024-06-144908 Devices Inc. (MASS)Option exercise (M): 7,777 · Option exercise (M): 7,777 (derivative) @ $0 · Grant/award (A): 11,364 (derivative) @ $0 · Grant/award (A): 15,996 (derivative) @ $0EDGAR
2024-06-144REPLIGEN CORP (RGEN)Purchase (P): 2,000 @ $124.08EDGAR
2024-05-224REPLIGEN CORP (RGEN)Sale (S): 4,274 @ $166.36 · Sale (S): 4,008 @ $167.05 · Sale (S): 3,933 @ $168.33 · Sale (S): 2,963 @ $169.27 · Sale (S): 3,925 @ $170.04 · Sale (S): 969 @ $171.03EDGAR
2024-03-204REPLIGEN CORP (RGEN)Gift (G): 2,000 @ $0EDGAR
2024-03-114REPLIGEN CORP (RGEN)Option exercise (M): 1 @ $16.55 · Sale (S): 3,377 @ $195.49 · Sale (S): 6,228 @ $196.32 · Sale (S): 1,666 @ $197.39 · Sale (S): 1,347 @ $198.55 · Sale (S): 1,822 @ $199.53 · +4 moreEDGAR
2024-03-074REPLIGEN CORP (RGEN)Tax withholding (F): 2,867 @ $195.72EDGAR
2024-03-064REPLIGEN CORP (RGEN)Tax withholding (F): 1,111 @ $193.99 · Tax withholding (F): 7,275 @ $195.52EDGAR
2024-03-054908 Devices Inc. (MASS)Option exercise (M): 2,057 · Option exercise (M): 2,057 (derivative) @ $0EDGAR
2024-03-044REPLIGEN CORP (RGEN)Grant/award (A): 2,504 @ $0 · Tax withholding (F): 3,322 @ $191.79EDGAR
2024-02-294REPLIGEN CORP (RGEN)Grant/award (A): 19,719 @ $0 · Grant/award (A): 19,585 (derivative) @ $0EDGAR
2023-11-164REPLIGEN CORP (RGEN)Gift (G): 1,000 @ $0EDGAR
2023-06-164908 Devices Inc. (MASS)Option exercise (M): 4,771 · Option exercise (M): 4,771 (derivative) @ $0 · Grant/award (A): 7,777 (derivative) @ $0 · Grant/award (A): 12,076 (derivative) @ $0EDGAR
2023-03-074908 Devices Inc. (MASS)Option exercise (M): 2,058 · Option exercise (M): 2,058 (derivative) @ $0EDGAR
2023-03-064REPLIGEN CORP (RGEN)Grant/award (A): 19,393 @ $0 · Grant/award (A): 18,584 @ $0 · Tax withholding (F): 8,244 @ $188 · Grant/award (A): 20,080 (derivative) @ $0EDGAR
2023-03-024REPLIGEN CORP (RGEN)Tax withholding (F): 2,748 @ $173.28 · Tax withholding (F): 6,670 @ $176.37EDGAR
2023-02-284REPLIGEN CORP (RGEN)Tax withholding (F): 3,273 @ $173.44EDGAR
2022-11-144REPLIGEN CORP (RGEN)Option exercise (M): 25,000 @ $33.87 · Sale (S): 25,000 @ $200 · Option exercise (M): 25,000 (derivative) @ $0EDGAR
2022-09-094REPLIGEN CORP (RGEN)Option exercise (M): 10,000 @ $33.87 · Sale (S): 824 @ $220.08 · Sale (S): 1,235 @ $221.46 · Sale (S): 720 @ $222.24 · Sale (S): 1,389 @ $223.26 · Sale (S): 6,626 @ $224.47 · +4 moreEDGAR
2022-07-224REPLIGEN CORP (RGEN)Option exercise (M): 5,000 @ $33.87 · Option exercise (M): 15,154 @ $32.40 · Sale (S): 24,802 @ $200 · Option exercise (M): 5,000 (derivative) @ $0 · Option exercise (M): 15,154 (derivative) @ $0EDGAR
2022-06-174908 Devices Inc. (MASS)Grant/award (A): 4,771 (derivative) @ $0 · Grant/award (A): 7,970 (derivative) @ $0EDGAR
2022-03-044908 Devices Inc. (MASS)Grant/award (A): 6,173 (derivative) @ $0 · Grant/award (A): 10,362 (derivative) @ $0EDGAR
2022-03-034REPLIGEN CORP (RGEN)Tax withholding (F): 7,292 @ $194.06EDGAR
2022-03-024REPLIGEN CORP (RGEN)Tax withholding (F): 2,754 @ $196.70 · Tax withholding (F): 3,170 @ $196.70 · Grant/award (A): 30,074 @ $0 · Tax withholding (F): 13,368 @ $196.70EDGAR
2022-02-284REPLIGEN CORP (RGEN)Grant/award (A): 15,855 @ $0 · Tax withholding (F): 1,170 @ $189.21 · Grant/award (A): 20,307 (derivative) @ $0EDGAR
2021-11-194REPLIGEN CORP (RGEN)Option exercise (M): 10,000 @ $32.40 · Sale (S): 2,061 @ $273.91 · Sale (S): 1,955 @ $274.83 · Sale (S): 4,017 @ $276.20 · Sale (S): 1,732 @ $277.01 · Sale (S): 6,024 @ $278.08 · +3 moreEDGAR
2021-09-134REPLIGEN CORP (RGEN)Option exercise (M): 25,000 @ $32.40 · Sale (S): 8,536 @ $294.22 · Sale (S): 14,825 @ $294.90 · Sale (S): 1,631 @ $296.09 · Sale (S): 8 @ $296.58 · Option exercise (M): 25,000 (derivative) @ $0EDGAR
2021-08-184REPLIGEN CORP (RGEN)Gift (G): 1,000 @ $0EDGAR
2021-05-204REPLIGEN CORP (RGEN)Sale (S): 612 @ $168.29 · Sale (S): 2,529 @ $169.45 · Sale (S): 7,911 @ $170.28 · Sale (S): 3,420 @ $171.32 · Sale (S): 3,036 @ $172.52 · Sale (S): 1,560 @ $173.19 · +2 moreEDGAR
2021-03-124REPLIGEN CORP (RGEN)Sale (S): 914 @ $188.06 · Sale (S): 1,171 @ $188.77 · Sale (S): 4,096 @ $190.17 · Sale (S): 1,081 @ $191.19 · Sale (S): 1,378 @ $192.17 · Sale (S): 227 @ $193.30 · +1 moreEDGAR
2021-03-084REPLIGEN CORP (RGEN)Sale (S): 794 @ $197.94 · Sale (S): 461 @ $196.44 · Sale (S): 1,082 @ $195.54 · Sale (S): 2,125 @ $194.43 · Sale (S): 6,193 @ $193.45 · Sale (S): 595 @ $187.48 · +3 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1606030 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs